Breakthrough T1D

We are a dedicated team of investment banking, pharma, company building, and business development veterans dedicated to catalyzing a world without T1D.

New York, NY, USA

Apply

Description

Breakthrough T1D, formerly JDRF, is a global nonprofit organization driving research, advocacy, and investment toward cures, treatments, and prevention for type 1 diabetes. Through its affiliated venture philanthropy arm, the T1D Fund, it co-invests with venture capital and biopharma in early-stage life sciences companies developing commercial disease-modifying therapies for T1D, leveraging Breakthrough T1D’s deep ecosystem expertise and networks.

Eligibility

General expectations based on the T1D Fund’s venture activity include:

Companies developing therapeutics, biologics, or disease-modifying technologies for T1D
Proof of concept or early clinical evidence
Scalability toward clinical or commercial validation with co-investor participation

What an Applicant can Obtain

Applicants or portfolio companies associated with Breakthrough T1D’s ecosystem and the T1D Fund may obtain:

Equity investment capital from the T1D Fund to advance therapies for T1D in partnership with venture capital and biopharma.
Access to Breakthrough T1D’s scientific, clinical, and advocacy network to accelerate development and adoption.
Strategic support and guidance through a venture philanthropy model that bridges nonprofit mission with commercial impact.

No standardized funding amount or equity percentage is publicly guaranteed; terms vary by investment.